Automation index
How much of a Nuclear medicine technologist’s job can AI already do?
A dose comes earlier. Injecting the isotope without contaminating the rest do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Nuclear medicine technologist
19%
AI can already do 19% of this job.
#617 / 713
View rankingNuclear medicine technologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Dose, calibrate and the patient.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 32% | +5.1 |
Inject, the vein and the one who moves.EstimateNo public source provides a precise figure. This is our estimate. | 22% | 8% | +1.8 |
Acquisition, the SPECT and the artefact.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Protection, the area and not contaminating.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The nuclear physician, the image and not repeating extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 18% | +2.9 |
Inject, and not contaminating the rest.EstimateNo public source provides a precise figure. This is our estimate. | 14% | 12% | +1.7 |
| Total | 100% | 19% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- isotopes
- calibrate doses
- SPECT
- radiopharmaceutical injection
- radiation protection
- contamination
- acquisition
- artefacts
Sources for this job· O*NET 29-2033.00· ESCO/ISCO 3211
IS WORK OVER?
In-house counsel
27%
#127 / 713
View rankingIn-house counsel
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Contract, clauses and the risk.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Sales, the close and not yielding the essential.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Dispute, the procurator and not sleeping the deadline.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Board, the memo and not dressing it.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The CEO, the rush and not signing blind.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Say no, and not leaving the company sold.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- commercial contracts
- clauses
- legal risk
- the board
- procedural deadlines
- sales
- not sign blind
- legal memos
Sources for this job· O*NET 23-1011.00· ESCO/ISCO 2611